Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA

International Journal of Drug Policy

Volumn 46, Issue , 2017, Pages 130-135

  Marshall, Brandon D L ^a   Krieger, Maxwell S ^a   Yedinak, Jesse L ^a   Ogera, Patricia ^b   Banerjee, Priya ^b   Alexander Scott, Nicole E ^b   Rich, Josiah D ^a,c,d   Green, Traci C ^a,c,e  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND DEPARTMENT OF HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

^d MIRIAM HOSPITAL   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; DRUG USE; EPIDEMIOLOGICAL DATA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; URBAN AREA; YOUNG ADULT; ADOLESCENT; EPIDEMIOLOGY; MEDICAL GEOGRAPHY; RHODE ISLAND;

ADOLESCENT; ADULT; DRUG OVERDOSE; FEMALE; FENTANYL; GEOGRAPHY, MEDICAL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHODE ISLAND; YOUNG ADULT;

EID: 85020417378     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2017.05.029     Document Type: Article

References (20)

1. British Columbia Coroners Service, Fentanyl-detected illicit drug overdose deaths: January 1, 2012 to September 30, 2016. 2016 Retrieved from http://www2.gov.bc.ca/assets/gov/public-safety-and-emergency-services/death-investigation/statistical/fentanyl-detected-overdose.pdf [Accessed 25 November 2016].
2. Centers for Disease and Control Prevention, Influx of fentanyl-laced counterfeit pills and toxic fentanyl-related compounds further increases risk of fentanyl-related overdose and fatalities. CDCHAN-00395. 2016 Retrieved from https://emergency.cdc.gov/han/han00395.asp [Accessed 16 September 2016].
3. Evans, T.I., Hadland, S.E., Clark, M.A., Green, T.C., Marshall, B.D., Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduction Journal, 13(1), 2016, 24.
4. Gladden, R.M., Martinez, P., Seth, P., Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. MMWR: Morbidity and Mortality Weekly Report 65:33 (2016), 837–843.
5. Green, T.C., Gilbert, M., Counterfeit medications and fentanyl. JAMA Internal Medicine 176:10 (2016), 1555–1557.
6. Han, B., Hedden, S.L., Lipari, R., Copello, E.A., Kroutil, L.A., Receipt of services for behavioral health problems: results from the 2014 National Survey on Drug Use and Health. 2015, Substance Abuse and Mental Health Services Administration, Rockville, MD.
7. Hess, R., Stiebler, G., Herz, A., Pharmacokinetics of fentanyl in man and the rabbit. European Journal of Clinical Pharmacology 4:3 (1972), 137–141.
8. Klar, S.A., Brodkin, E., Gibson, E., Padhi, S., Predy, C., Green, C., et al. Notes from the Field: furanyl–fentanyl overdose events caused by smoking contaminated crack cocaine—British Columbia, Canada, July 15–18, 2016. MMWR: Morbidity and Mortality Weekly Report 65:37 (2016), 1015–1016.
9. Latimer, J., Ling, S., Flaherty, I., Jauncey, M., Salmon, A.M., Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre. International Journal on Drug Policy, 2016, 37111–37114.
10. Marinetti, L.J., Ehlers, B.J., A series of forensic toxicology and drug seizure cases involving illicit fentanyl alone and in combination with heroin, cocaine or heroin and cocaine. Journal of Analytical Toxicology 38:8 (2014), 592–598.
11. Marshall, B.D.L., Milloy, M.J., Wood, E., Montaner, J.S., Kerr, T., Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. The Lancet 377:9775 (2011), 1429–1437.
12. Peterson, A.B., Gladden, R.M., Delcher, C., Spies, E., Garcia-Williams, A., Wang, Y., et al. Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013–2015. MMWR: Morbidity and Mortality Weekly Report 65:33 (2016), 844–849.
13. Rhode Island Department of Health, Policy: indentifying and reporting confirmed accidental drug-related overdose deaths., 2015 Retrieved from http://www.health.ri.gov/publications/policies/IdentifyingAndReportingConfirmedAccidentalDrugRelatedOverdoseDeaths.pdf [Accessed 26 October 2016].
14. Rudd, R.A., Seth, P., David, F., Scholl, L., Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR: Morbidity and Mortality Weekly Report 65:5051 (2016), 1445–1452.
15. Samuels, E., Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths. Rhode Island Medical Journal 97:10 (2014), 38–39.
16. Schwartz, R.P., Gryczynski, J., O'Grady, K.E., Sharfstein, J.M., Warren, G., Olsen, Y., et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health 103:5 (2013), 917–922.
17. US Drug Enforcement Administration, DEA issues nationwide alert on fentanyl as threat to health and public safety. 2015 Retrieved from http://www.dea.gov/divisions/hq/2015/hq031815.shtml [Accessed 16 September 2016].
18. US Drug Enforcement Administration, Counterfeit prescription pills containing fentanyls: a global threat. 2016 Retrieved from https://www.dea.gov/docs/Counterfeit%20Prescription%20Pills.pdf [Accessed 15 September 2016].
19. Walley, A.Y., Xuan, Z., Hackman, H.H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. British Medical Journal, 346, 2013, f174.
20. Woody, G.E., Poole, S.A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., et al. Extended vs short-term buprenorphine–naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA The Journal of the American Medical Association 300:17 (2008), 2003–2011.